logo

Vir Biotechnology (VIR)



Trade VIR now with
  Date
  Headline
8/23/2021 8:36:35 AM Vir Biotechnology Announces First Marketing Authorization For Sotrovimab, Granted In Australia
6/25/2021 8:57:42 AM Vir Biotechnology Presents New Clinical Data From Ongoing Trials Of VIR-2218, VIR-3434
4/21/2021 8:12:59 AM Brii Biosciences, Vir Biotechnology, VBI Vaccines Begin Phase 2 Clinical Trial Of BRII-835 In Combination With BRII-179
4/5/2021 8:05:05 AM Vir Biotechnology Announces New Preclinical Research Demonstrating Ability Of VIR-7831
3/29/2021 8:31:48 AM Lilly, Vir Biotechnology, GSK Announce Positive Topline Data From Phase 2 BLAZE-4 Trial In Low-Risk Adults With COVID-1
3/26/2021 9:07:40 AM GSK, Vir Announce Submission Of Emergency Use Authorization Request To FDA For VIR-7831
2/17/2021 7:31:34 AM GlaxoSmithKline And Vir Biotechnology Sign Binding Agreement To Expand Existing Collaboration
1/27/2021 6:46:51 AM Lilly, Vir Biotechnology And GSK Announce First Patient Dosed In Expanded BLAZE-4 Trial For COVID-19